Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys
- PMID: 15226039
- DOI: 10.1016/j.ypmed.2004.04.022
Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys
Abstract
Background: Relatively little is known about the prevalence of skin cancer screening in the context of inconsistent skin cancer screening recommendations.
Methods: To determine the prevalence and predictors of skin cancer screening rates in the U.S. adult population, we used self-reported data from the 1992, 1998, and 2000 National Health Interview Surveys, a nationally representative survey of civilian noninstitutionalized adults.
Results: The percentage of the U.S. adult population who had ever had a skin examination conducted by a doctor was 20.6% in 1992, 20.9% in 1998, and 14.5% in 2000. The percentage with a recent skin examination was 10.3% in 1992, 11.0% in 1998, and 8.0% in 2000. White non-Hispanics reported being screened more frequently than persons in other racial or ethnic groups. Recent skin cancer screening exams were more common among white persons who had a family history of melanoma, had higher education, had usual place of care, and were older (> or =50 years). Frequent use of sunscreen and hats was associated with a recent skin cancer exam.
Conclusions: In the past decade, skin cancer screening rates have been consistently low. Continued monitoring of skin cancer examination is important given conflicting current research results and potentially evolving science.
Similar articles
-
Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.Prev Med. 2004 Aug;39(2):270-8. doi: 10.1016/j.ypmed.2004.03.035. Prev Med. 2004. PMID: 15226035
-
Physician recommendation for papanicolaou testing among U.S. women, 2000.Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1143-8. doi: 10.1158/1055-9965.EPI-04-0559. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15894664
-
Cancer screening among Latino subgroups in the United States.Prev Med. 2005 May;40(5):515-26. doi: 10.1016/j.ypmed.2004.09.031. Prev Med. 2005. PMID: 15749133
-
Disparities in cholesterol screening: falling short of a national health objective.Prev Med. 2001 Dec;33(6):517-22. doi: 10.1006/pmed.2001.0928. Prev Med. 2001. PMID: 11716645
-
Decision making in prostate-specific antigen screening National Health Interview Survey, 2000.Am J Prev Med. 2006 May;30(5):394-404. doi: 10.1016/j.amepre.2005.12.006. Epub 2006 Mar 23. Am J Prev Med. 2006. PMID: 16627127
Cited by
-
Screening for reducing morbidity and mortality in malignant melanoma.Cochrane Database Syst Rev. 2019 Jun 3;6(6):CD012352. doi: 10.1002/14651858.CD012352.pub2. Cochrane Database Syst Rev. 2019. PMID: 31157404 Free PMC article.
-
Skin examination behavior: the role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination.Arch Dermatol. 2012 Oct;148(10):1142-51. doi: 10.1001/archdermatol.2012.1817. Arch Dermatol. 2012. PMID: 22801744 Free PMC article.
-
Skin cancer-related prevention and screening behaviors: a review of the literature.J Behav Med. 2009 Oct;32(5):406-28. doi: 10.1007/s10865-009-9219-2. Epub 2009 Jun 12. J Behav Med. 2009. PMID: 19521760
-
Cancer screening in a middle-aged general population: factors associated with practices and attitudes.BMC Public Health. 2009 Apr 29;9:118. doi: 10.1186/1471-2458-9-118. BMC Public Health. 2009. PMID: 19402895 Free PMC article.
-
Contributions by MC1R Variants to Melanoma Risk in Males and Females.JAMA Dermatol. 2018 Jul 1;154(7):789-795. doi: 10.1001/jamadermatol.2018.1252. JAMA Dermatol. 2018. PMID: 29898205 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous